4//SEC Filing
Blanchard Cheryl R 4
Accession 0001171843-25-001467
CIK 0000898437other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:15 PM ET
Size
10.2 KB
Accession
0001171843-25-001467
Insider Transaction Report
Form 4
Blanchard Cheryl R
DirectorPresident, CEO, Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-11+30,060→ 197,015 total - Tax Payment
Common Stock
2025-03-11$16.79/sh−12,675$212,813→ 184,340 total - Exercise/Conversion
Restricted Stock Unit
2025-03-11−30,060→ 0 totalExercise: $0.00→ Common Stock (30,060 underlying)
Holdings
- 11,742(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Reflects the third and final vesting installment of RSUs granted on March 11, 2022.
- [F2]Reflects an aggregate of 12,675 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025.
- [F3]Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001326530
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:15 PM ET
- Size
- 10.2 KB